Radebeul, Germany

Thomas Pfeifer


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Thomas Pfeifer: Innovator in Neurological Therapy

Introduction: Thomas Pfeifer, based in Radebeul, Germany, is a prominent inventor recognized for his contributions in the field of pharmaceuticals. His innovative work has led to the development of a significant patent in the treatment of neurological and psychiatric disorders, paving the way for new therapeutic options.

Latest Patents: Thomas Pfeifer holds a patent for "Pyrido[3,2-e]pyrazines, their use as inhibitors of phosphodiesterase 10, and processes for preparing them." This invention details pyrido[3,2-e]pyrazines and their applications as inhibitors of phosphodiesterase 10. This compound is proposed for use in treating various diseases that affect mammals, including humans. The patent specifically targets the inhibition of phosphodiesterase 10 activity within the central nervous system, focusing on its potential for addressing neurological and psychiatric disorders such as psychosis and cognitive deficits.

Career Highlights: Employed at Elbion GmbH, Thomas Pfeifer’s career has been marked by his dedication to advancing therapeutic solutions for complex health issues. His singular patent showcases his ability to innovate and contribute meaningfully to the pharmaceutical industry, highlighting his role as a key figure in enhancing treatment methodologies.

Collaborations: Throughout his career, Thomas Pfeifer has collaborated with esteemed professionals such as Norbert Höfgen and Hans Stange. These partnerships have likely enriched his projects and aided in pushing the boundaries of research in pharmaceutical sciences.

Conclusion: Thomas Pfeifer is a notable inventor whose work with pyrido[3,2-e]pyrazines represents a critical advancement in the treatment of neurological conditions. His collaboration with other talented professionals at Elbion GmbH emphasizes the significance of teamwork in driving innovation in healthcare. Through his contributions, he continues to offer hope for improved treatment options for various psychiatric and neurological disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…